Weitz-Schmidt G - Search Results

1

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.

Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U. Weitz-Schmidt G, et al. Nat Med. 2001 Jun;7(6):687-92. doi: 10.1038/89058. Nat Med. 2001. PMID: 11385505

2

Assembly of binding loops on aromatic templates as VCAM-1 mimetics.

Peri F, Grell D, Dumy P, Yokokawa Y, Welzenbach K, Weitz-Schmidt G, Mutter M. Peri F, et al. J Pept Sci. 1999 Jul;5(7):313-22. doi: 10.1002/(SICI)1099-1387(199907)5:7<313::AID-PSC200>3.0.CO;2-F. J Pept Sci. 1999. PMID: 10442767

3

Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.

Kallen J, Welzenbach K, Ramage P, Geyl D, Kriwacki R, Legge G, Cottens S, Weitz-Schmidt G, Hommel U. Kallen J, et al. J Mol Biol. 1999 Sep 10;292(1):1-9. doi: 10.1006/jmbi.1999.3047. J Mol Biol. 1999. PMID: 10493852

4

Small molecule inhibitors induce conformational changes in the I domain and the I-like domain of lymphocyte function-associated antigen-1. Molecular insights into integrin inhibition.

Welzenbach K, Hommel U, Weitz-Schmidt G. Welzenbach K, et al. J Biol Chem. 2002 Mar 22;277(12):10590-8. doi: 10.1074/jbc.M110521200. Epub 2002 Jan 7. J Biol Chem. 2002. PMID: 11781316 Free article.

5

Statins as anti-inflammatory agents.

Weitz-Schmidt G. Weitz-Schmidt G. Trends Pharmacol Sci. 2002 Oct;23(10):482-6. doi: 10.1016/s0165-6147(02)02077-1. Trends Pharmacol Sci. 2002. PMID: 12368073 Review.

6

1,4-Diazepane-2-ones as novel inhibitors of LFA-1.

Wattanasin S, Albert R, Ehrhardt C, Roche D, Sabio M, Hommel U, Welzenbach K, Weitz-Schmidt G. Wattanasin S, et al. Bioorg Med Chem Lett. 2003 Feb 10;13(3):499-502. doi: 10.1016/s0960-894x(02)00991-5. Bioorg Med Chem Lett. 2003. PMID: 12565959

7

Lymphocyte function-associated antigen-1 blockade by statins: molecular basis and biological relevance.

Weitz-Schmidt G. Weitz-Schmidt G. Endothelium. 2003;10(1):43-7. doi: 10.1080/10623320303360. Endothelium. 2003. PMID: 12699076 Review.

8

A statin-based inhibitor of lymphocyte function antigen-1 protects against ischemia/reperfusion-induced leukocyte adhesion in the colon.

Wan MX, Schramm R, Klintman D, Welzenbach K, Weitz-Schmidt G, Thorlacius H. Wan MX, et al. Br J Pharmacol. 2003 Sep;140(2):395-401. doi: 10.1038/sj.bjp.0705432. Epub 2003 Aug 26. Br J Pharmacol. 2003. PMID: 12970101 Free PMC article.

9

Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.

Ullrich T, Baumann K, Welzenbach K, Schmutz S, Camenisch G, Meingassner JG, Weitz-Schmidt G. Ullrich T, et al. Bioorg Med Chem Lett. 2004 May 17;14(10):2483-7. doi: 10.1016/j.bmcl.2004.03.006. Bioorg Med Chem Lett. 2004. PMID: 15109637

10

Improved lymphocyte function-associated antigen-1 (LFA-1) inhibition by statin derivatives: molecular basis determined by x-ray analysis and monitoring of LFA-1 conformational changes in vitro and ex vivo.

Weitz-Schmidt G, Welzenbach K, Dawson J, Kallen J. Weitz-Schmidt G, et al. J Biol Chem. 2004 Nov 5;279(45):46764-71. doi: 10.1074/jbc.M407951200. Epub 2004 Aug 10. J Biol Chem. 2004. PMID: 15304496 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters